-
Innovation Ranking
NewInnovation Ranking – Adamis Pharmaceuticals Corp
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company. The company's pipeline products includes SYMJEPI (epinephrine), ZIMHI(naloxone) and APC-400 (tempol). Its SYMJEPI Injection is used for the emergency treatment of allergic reactions such as caused by the stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and other allergens, idiopathic and exercise-induced anaphylaxis. Adamis develops products in the form of injections, gels and capsules for the treatment of allergy, opioid overdose, respiratory and inflammatory...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy For Oncology 1 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellular Immunotherapy For Oncology 1 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy For Oncology 1 in Gastric Cancer...
-
Product Insights
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Dry Powder Inhaler Devices Pipeline Market Report Overview Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder. The Dry Powder Inhaler Devices pipeline market research report provides comprehensive information about the Dry Powder Inhaler Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories ·       The US ·       China ·       Europe ·       Global ·       Australia Key...
-
Product Insights
Inhalers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Inhalers Pipeline Market Report Overview Inhalers deliver medication to the lungs. The inhalers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segment ·       Dry Powder Inhaler Devices Key Territories ·       The US ·       Europe ·       Australia...
-
Company Profile
Adamis Pharmaceuticals Corp – Company Profile
DMK Pharmaceuticals Corp (DMK), formerly Adamis Pharmaceuticals Corporation, is a commercial-stage neuro-biotech company that develops and commercializes products for the treatment of opioid overdose and substance use disorders. The company’s pipeline includes SYMJEPI, ZIMHI, DPI-125, DPI-221 and DPI-289. Its pipeline candidates treat anaphylaxis, opioid overdose, opioid use disorder, benign prostatic hyperplasia and parkinson’s disease. DMK develops products in the form of injections, gels and capsules for the treatment of allergies, opioid overdose and respiratory and inflammatory disease. The company supplies...
Add to Basket -
Product Insights
Metered Dose Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Metered Dose Inhaler Devices delivers a specific amount of medication to lungs and GI tract. It is mostly used by asthma and COPD patients. GlobalData's Medical Devices sector report, “Metered Dose Inhaler Devices - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Metered Dose Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Metered Dose Inhaler Devices report provides key...
-
Product Insights
Bronchospasm Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2017" provides an overview of Bronchospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Ichthyosis Vulgaris Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Ichthyosis Vulgaris Global Clinical Trials Review, H2, 2017" provides an overview of Ichthyosis Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Ichthyosis Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Drug Overdose Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Drug Overdose Global Clinical Trials Review, H1, 2019" provides an overview of Drug Overdose clinical trials scenario. This report provides top line data relating to the clinical trials on Drug Overdose. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Bronchospasm Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H2, 2018" provides an overview of Bronchospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...